These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 10843199)
1. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. Huizenga NA; de Lange P; Koper JW; de Herder WW; Abs R; Kasteren JH; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 2000 May; 85(5):2076-81. PubMed ID: 10843199 [TBL] [Abstract][Full Text] [Related]
2. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680 [TBL] [Abstract][Full Text] [Related]
3. Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. Lamberts SW; Koper JW; Biemond P; den Holder FH; de Jong FH J Clin Endocrinol Metab; 1992 Feb; 74(2):313-21. PubMed ID: 1309833 [TBL] [Abstract][Full Text] [Related]
4. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor. Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689 [TBL] [Abstract][Full Text] [Related]
5. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. Huizenga NA; Koper JW; De Lange P; Pols HA; Stolk RP; Burger H; Grobbee DE; Brinkmann AO; De Jong FH; Lamberts SW J Clin Endocrinol Metab; 1998 Jan; 83(1):144-51. PubMed ID: 9435432 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology. Stratakis CA; Karl M; Schulte HM; Chrousos GP Ann N Y Acad Sci; 1994 Nov; 746():362-74; discussion 374-6. PubMed ID: 7825890 [TBL] [Abstract][Full Text] [Related]
7. The N363S and I559N single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients with bronchial asthma. Panek M; Pietras T; Antczak A; Fabijan A; Przemęcka M; Górski P; Kuna P; Szemraj J Int J Mol Med; 2012 Jul; 30(1):142-50. PubMed ID: 22469783 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach. van Rossum EF; Lamberts SW Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):611-26. PubMed ID: 17161335 [TBL] [Abstract][Full Text] [Related]
9. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor polymorphism affects transrepression but not transactivation. van den Akker EL; Russcher H; van Rossum EF; Brinkmann AO; de Jong FH; Hokken A; Pols HA; Koper JW; Lamberts SW J Clin Endocrinol Metab; 2006 Jul; 91(7):2800-3. PubMed ID: 16684836 [TBL] [Abstract][Full Text] [Related]
12. Strategies for the characterization of disorders in cortisol sensitivity. Russcher H; Smit P; van Rossum EF; van den Akker EL; Brinkmann AO; de Heide LJ; de Jong FH; Koper JW; Lamberts SW J Clin Endocrinol Metab; 2006 Feb; 91(2):694-701. PubMed ID: 16317053 [TBL] [Abstract][Full Text] [Related]
13. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988 [TBL] [Abstract][Full Text] [Related]
14. Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation. Trebble P; Matthews L; Blaikley J; Wayte AW; Black GC; Wilton A; Ray DW J Clin Endocrinol Metab; 2010 Dec; 95(12):E490-9. PubMed ID: 20861124 [TBL] [Abstract][Full Text] [Related]
15. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230 [TBL] [Abstract][Full Text] [Related]
16. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene. Mendonca BB; Leite MV; de Castro M; Kino T; Elias LL; Bachega TA; Arnhold IJ; Chrousos GP; Latronico AC J Clin Endocrinol Metab; 2002 Apr; 87(4):1805-9. PubMed ID: 11932321 [TBL] [Abstract][Full Text] [Related]
17. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies. Lee S; Duncan KA; Chou H; Chen D; Kohli K; Huang CF; Stallcup MR Mol Endocrinol; 1995 Jul; 9(7):826-37. PubMed ID: 7476966 [TBL] [Abstract][Full Text] [Related]
19. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760 [TBL] [Abstract][Full Text] [Related]